Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: Evidence of causal association from population studies

PLoS Medicine

Volumn 8, Issue 10, 2011, Pages

  Pfister, Roman ^a,b   Sharp, Stephen ^a   Luben, Robert ^c   Welsh, Paul ^d   Barroso, Inês ^a,e   Salomaa, Veikko ^f   Meirhaeghe, Aline ^g   Khaw, Kay Tee ^c   Sattar, Naveed ^d   Langenberg, Claudia ^a   Wareham, Nicholas J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; GENE LOCUS; GENOTYPE; HUMAN; HYPERTENSION; INCIDENCE; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; FEMALE; GENETIC VARIABILITY; GENETICS; MALE; META ANALYSIS (TOPIC); METABOLISM; MIDDLE AGED; RISK ASSESSMENT;

AGED; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 80055060938     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001112     Document Type: Article

References (33)

1. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM, (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol pp. 341-366.
2. Sengenes C, Berlan M, de Glisezinski I, Lafontan M, Galitzky J, (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14: 1345-1351.
3. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594-600.
4. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, et al. (2007) Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115: 1345-1353.
5. Meirhaeghe A, Sandhu MS, McCarthy MI, de Groote P, Cottel D, et al. (2007) Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 16: 1343-1350.
6. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, et al. (2009) Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41: 348-353.
7. Halbirk M, Norrelund H, Moller N, Schmitz O, Botker HE, et al. (2010) Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. Int J Cardiol 144: 140-142.
8. Chainani-Wu N, Weidner G, Purnell DM, Frenda S, Merritt-Worden T, et al. (2010) Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes. Am J Cardiol 105: 1570-1576.
9. van Kimmenade R, van Dielen F, Bakker J, Nijhuis J, Crijns H, et al. (2006) Is brain natriuretic peptide production decreased in obese subjects? J Am Coll Cardiol 47: 886-887.
10. Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS, (2006) B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152: 1071-1076.
11. Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, et al. (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS ONE 5: e10100 doi:10.1371/journal.pone.0010100.
12. Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ, (2003) Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case- control study. Hum Mol Genet 12: 1361-1365.
13. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, et al. (2000) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24 (Suppl 3): S6-S11.
14. Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, et al. (2007) TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56: 1943-1947.
15. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
16. Day N, Oakes S, Luben R, Khaw KT, Bingham S, et al. (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 (Suppl 1): 95-103.
17. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, et al. (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141: 413-420.
18. McFadden E, Luben R, Wareham N, Bingham S, Khaw KT, (2008) Occupational social class, educational level, smoking and body mass index, and cause-specific mortality in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol 23: 511-522.
19. Choquet H, Cavalcanti-Proenca C, Lecoeur C, Dina C, Cauchi S, et al. (2009) The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 18: 2495-2501.
20. Onland-Moret NC, van der A DL, van der Schouw YT, Buschers W, Elias SG, et al. (2007) Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol 60: 350-355.
21. Takeishi Y, Toriyama S, Takabatake N, Shibata Y, Konta T, et al. (2007) Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. Biochem Biophys Res Commun 362: 480-484.
22. Lanfear DE, Stolker JM, Marsh S, Rich MW, McLeod HL, (2007) Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 21: 55-62.
23. Didelez V, Sheehan N, (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16: 309-330.
24. Thomas DC, Lawlor DA, Thompson JR, (2007) Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista, et al. Ann Epidemiol 17: 511-513.
25. De Silva NM, Freathy RM, Palmer TM, Donnelly LA, Luan J, et al. (2011) Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes 60: 1008-1018.
26. Wang TJ, Levy D, Benjamin EJ, Vasan RS, (2003) The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138: 907-916.
27. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
28. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, et al. (2009) Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58: 2880-2892.
29. Soriano S, Ropero AB, Alonso-Magdalena P, Ripoll C, Quesada I, et al. (2009) Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol Endocrinol 23: 1973-1982.
30. Ropero AB, Soriano S, Tuduri E, Marroqui L, Tellez N, et al. (2010) The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. Endocrinology 151: 3665-3674.
31. Huang WS, Lee MS, Perng HW, Yang SP, Kuo SW, et al. (2002) Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 51: 1423-1426.
32. Mohammed SF, Korinek J, Chen HH, Burnett JC, Redfield MM, (2008) Nesiritide in acute decompensated heart failure: current status and future perspectives. Rev Cardiovasc Med 9: 151-158.
33. Ritchie RH, Rosenkranz AC, Kaye DM, (2009) B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med 9: 814-825.